NASDAQ:MATK
$22.82   + 0.23 		Mar 11, 2010
3:59 PM ET

Martek Biosciences Corporation

Celebrating 15 years with NASDAQ

Home • Investors • Financial Information

Financial Information

Here you will find a summary of Martek Biosciences Corporation's latest financial information.

Latest Earnings Release and 10-Q Date Filed Format Size  
First Quarter Financial Results HTML file N/A  
 
Latest Annual Report and 10-K Date Filed Format Size  
2009 Form 10-K   HTML file N/A  
Form 10-K Dec 29, 2009 HTML file  PDF file 1.0 MB Add to Briefcase
 
Latest Proxy Statement Date Filed Format Size  
Proxy Statement Feb 3, 2010 HTML file  PDF file 416.2 KB Add to Briefcase
Add to Briefcase = add file to Briefcase